Tetanus vaccination and risk of multiple sclerosis: a systematic review

Neurology. 2006 Jul 25;67(2):212-5. doi: 10.1212/01.wnl.0000225079.51201.f9.

Abstract

Objective: To conduct a systematic review on the association between tetanus vaccination and the risk of multiple sclerosis (MS).

Methods: The authors searched the databases Medline, LILACS, EMBASE, and Science Citation Index including the period 1966 to September 1, 2005. Eligible studies had to meet the following inclusion criteria: presentation of original data, case-control or cohort design, physician-confirmed diagnosis of MS as the outcome of interest, attempt to ascertain vaccinations in a period before the diagnosis, and report of an association measure between tetanus vaccination and incidence of MS, and its 95% CI or enough information to compute it. Study specific log ORs were weighted by the inverse of their variances to obtain a pooled estimate and its 95% CI.

Results: The OR of MS associated with history of tetanus vaccination was 0.67 (95% CI: 0.55 to 0.81). There was little indication of heterogeneity of results across studies.

Conclusion: Tetanus vaccination is associated with a lower risk of multiple sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Clinical Trials as Topic / statistics & numerical data
  • Humans
  • Incidence
  • Multiple Sclerosis / epidemiology*
  • Multiple Sclerosis / prevention & control*
  • Outcome Assessment, Health Care / methods
  • Prognosis
  • Risk Assessment / methods*
  • Risk Factors
  • Tetanus Toxoid / administration & dosage*
  • Vaccination / statistics & numerical data*

Substances

  • Tetanus Toxoid